Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest & Investment Income (2016 - 2022)

Abeona Therapeutics (ABEO) has 12 years of Interest & Investment Income data on record, last reported at $30000.0 in Q2 2022.

  • For Q2 2022, Interest & Investment Income rose 275.0% year-over-year to $30000.0; the TTM value through Jun 2022 reached $77000.0, down 76.95%, while the annual FY2021 figure was $69000.0, 94.7% down from the prior year.
  • Interest & Investment Income reached $30000.0 in Q2 2022 per ABEO's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $652000.0 in Q1 2020 and bottomed at $1000.0 in Q1 2022.
  • Average Interest & Investment Income over 5 years is $212312.5, with a median of $104000.0 recorded in 2018.
  • Peak YoY movement for Interest & Investment Income: surged 2280.95% in 2018, then plummeted 97.7% in 2021.
  • A 5-year view of Interest & Investment Income shows it stood at $533000.0 in 2018, then crashed by 48.03% to $277000.0 in 2019, then crashed by 85.56% to $40000.0 in 2020, then fell by 10.0% to $36000.0 in 2021, then dropped by 16.67% to $30000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $30000.0 in Q2 2022, $1000.0 in Q1 2022, and $36000.0 in Q4 2021.